John M. Kirkwood, M.D., Honored By American Cancer Society For Outstanding Contributions To Cancer Research
PITTSBURGH, September 27, 2004 John M. Kirkwood, M.D., professor of medicine and vice chairman for clinical research at the University of Pittsburgh and director of the Melanoma Center at the University of Pittsburgh Cancer Institute, will be honored by the Pennsylvania Division of the American Cancer Society (ACS), at a reception this evening from 6:30 to 8:30 p.m. at the Pittsburgh Athletic Association in Oakland. Dr. Kirkwood is being recognized by the ACS for his outstanding cancer research contributions and will speak on new advances in cancer treatment.
Dr. Kirkwood established the first medical treatment that is capable of preventing melanoma relapse and death and is a recognized leader who is called on for his expertise both nationally and abroad based on his pioneering work with biological therapy, said Karen Kutzer, state director of donor development, ACS, Pennsylvania Division. His research has touched the lives of many cancer patients and their families and has had an unsurpassed impact on moving the field of cancer research forward.
As chair of the biologics and melanoma committees of the Eastern Cooperative Oncology Group, Dr. Kirkwood is currently responsible for a number of highly promising new clinical trials of cancer vaccines designed to spur the bodies immune system into recognizing and destroying melanoma the most serious form of skin cancer that accounts for most skin cancer-related deaths.
The American Cancer Society recognizes and celebrates distinguished research achievements in cancer in southwestern Pennsylvania. The ACS is a nationwide community-based voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer, saving lives and diminishing suffering from cancer through research, education, advocacy and service.